alovudine has been researched along with Metastase in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akoury, J; Douglas, KA; Gadgeel, S; Lawhorn-Crews, JM; Li, J; Mangner, TJ; McHugh, CI; Polin, L; Ratnam, M; Shields, AF; Thipparthi, MR | 1 |
| Babur, M; Brown, G; Burrows, N; Cawthorne, C; Dive, C; Forster, D; Gieling, RG; Gregory, J; Hiscock, D; Hodgkinson, C; McMahon, A; Morrow, CJ; Radigois, M; Simpson, K; Smigova, A; Williams, KJ; Wilson, I | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
| Guo, W; Hu, S; Li, J; Wang, C; Yao, Z; Zhang, Y; Zhou, M | 1 |
| Boellaard, R; Frings, V; Giovannetti, E; Herder, GJ; Hoekstra, OS; Honeywell, R; Peters, GJ; Smit, EF; Thunnissen, E; van der Veldt, AA | 1 |
| Hong, YS; Kim, HJ; Kim, HO; Kim, JS; Kim, KP; Kim, TW; Lee, JL; Lee, SJ; Moon, DH; Oh, SJ; Ryu, JS | 1 |
| Aboagye, EO; Barwick, T; Challapalli, A; Howell, EC; Mauri, F; Maxwell, RJ; Merchant, S; Pearson, RA; Sharma, R; Sumpter, K | 1 |
| Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
| Małkowski, B; Śrutek, E; Staniuk, T; Szlęzak, P; Zegarski, W | 1 |
| Chen, Y; Li, T; Liu, J; Qu, B; Tian, J; Wang, H; Wang, S; Zhang, J | 1 |
| Allen-Auerbach, MS; Benz, MR; Chmielowski, B; Czernin, J; Gomez-Navarro, J; McCarthy, T; Radu, C; Ribas, A; Seja, E; Williams, JL | 1 |
| Aschoff, P; Bares, R; Claussen, CD; Dittmann, H; Hartmann, JT; Kanz, L; Mayer, F; Pfannenberg, C; Reischl, G; von Weyhern, C | 1 |
| Aboagye, EO; Al-Nahhas, A; Coombes, RC; Kenny, L; Shousha, S; Vigushin, DM | 1 |
| Kumar, R | 1 |
2 trial(s) available for alovudine and Metastase
| Article | Year |
|---|---|
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Positron-Emission Tomography; Survival Analysis; Time Factors; Treatment Outcome | 2013 |
Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Cell Proliferation; CTLA-4 Antigen; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed; Tumor Burden | 2010 |
12 other study(ies) available for alovudine and Metastase
| Article | Year |
|---|---|
Using Radiolabeled 3'-Deoxy-3'-
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Dexamethasone; Dideoxynucleosides; Humans; Isotope Labeling; Lung Neoplasms; Mice; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Treatment Outcome | 2018 |
[18F]-FLT positron emission tomography can be used to image the response of sensitive tumors to PI3-kinase inhibition with the novel agent GDC-0941.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dideoxynucleosides; Disease Models, Animal; Female; HCT116 Cells; Humans; Indazoles; Mice; Neoplasm Metastasis; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Positron-Emission Tomography; Signal Transduction; Sulfonamides; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
The value of 18F-FLT PET for detecting second primary cancers and distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dideoxynucleosides; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Pemetrexed; Polymorphism, Genetic; Positron-Emission Tomography; Prognosis; Thymidylate Synthase; Time Factors; Tissue Distribution | 2013 |
3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.
Topics: Aged; Aged, 80 and over; Deoxycytidine; Dideoxynucleosides; Female; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Comparison of FLT-PET/CT and CECT in gastric cancer diagnosis.
Topics: Aged; Contrast Media; Dideoxynucleosides; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Topics: Animals; Biological Transport; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Linear Models; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed | 2009 |
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?
Topics: Adult; Dideoxynucleosides; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Proliferation; Cyclophosphamide; Dideoxynucleosides; Epirubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Kinetics; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Treatment Outcome | 2007 |
Assessment of therapy response in malignant tumours with 18F-fluorothymidine.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Dideoxynucleosides; Humans; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |